RecruitingPhase 1NCT03911388
Blood
Anaplastic astrocytoma
25
studies recruiting now
as of 7 Sept 2026
460
studies registered in total
as of 7 Sept 2026
15
countries with a recruiting site
as of 7 Sept 2026
7 Feb 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1 / Phase 2NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 2NCT06161974
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 1 / Phase 2NCT05765812
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1 / Phase 2NCT06814496
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 25 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Anaplastic astrocytoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Anaplastic astrocytoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (IDH2).
Treatments being studied
1 approved treatment and 23 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Procarbazine Hydrochloride (Matulane)
Phase 3Lomustine (Ccnu)
Phase 3Temozolomide (Temodal)
Phase 3Eflornithine
Phase 2/3Vocimagene Amiretrorepvec
Phase 2/3Bevacizumab (Abevmy)
Phase 2Talaporfin Sodium
Phase 2Etirinotecan Pegol
Phase 2Talampanel
+ 15 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).